LPL Financial LLC - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,537
-36.6%
16,912
-2.3%
0.00%
Q3 2022$4,000
-42.9%
17,3120.0%0.00%
Q2 2022$7,000
-41.7%
17,312
-4.2%
0.00%
Q1 2022$12,000
-33.3%
18,0620.0%0.00%
Q4 2021$18,000
-28.0%
18,062
-0.1%
0.00%
Q3 2021$25,000
-53.7%
18,075
+17.9%
0.00%
Q2 2021$54,000
-46.0%
15,325
+5.1%
0.00%
Q1 2021$100,00014,5750.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders